Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PETSied Kebir, Ulrich Herrlinger, Theophilos Tzaridis et al.|Clinical Cancer Research|2015Cited by 126
Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany – A national case collectionPawel Kermer, Robert Wruck, Christoph Eschenfelder et al.|International Journal of Stroke|2017Cited by 92
Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumorsNiklas Schäfer, Martin Glas, Gerrit H. Gielen et al.|Journal of Translational Medicine|2019Cited by 78
Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human GlioblastomaRoman Reinartz, Björn Scheffler, Shanshan Wang et al.|Clinical Cancer Research|2016Cited by 72